Dig Howitt, the CEO of Cochlear, also talks about how the company navigates tariff and supply chain issues, and the new Nucleus Nexa "smart" implant.

The medical device maker expects full-year earnings to land near the bottom end of its forecast range, and has written down its investment in Saluda.

Monday - Friday, 10:00 - 11:00 SIN/HK | 0400 - 05:00 CET In this video Cochlear CEO Dig Howitt says its medical devices are largely exempt from tariffs. He also talks about the latest innovations and ...

LONE TREE, Colo., March 3, 2025 /PRNewswire/ — In celebration of World Hearing Day, Cochlear, the global leader in implantable hearing solutions, is proud to announce that it has been named the number ...

Hearing device manufacturer Cochlear has suffered a 19 per cent sell-off after posting weaker-than-expected half-year earnings and trimming its guidance.

Thank you for standing by, and welcome to the Cochlear Limited Half Year 2025 Results Analyst and Media Briefing. All participants are in listen-only mode. There will be presentation, followed by a ...

Dig Howitt, CEO and President of Cochlear, discusses the company's half-year earnings, potential impact of tariffs on the business, and the plunge in the company's share price. Got a confidential news ...

SYDNEY >> Hearing impaired children in Japan’s coastal city of Shizuoka will from next year be able to listen, learn and speak better thanks to an A$6.5 million ($4.4 million) programme funded by the ...

Thank you for standing by. And welcome to the Cochlear Limited FY 2024 Results, Analyst and Media Briefing. All participants are in a listen-only mode. There will be a presentation followed by a ...